| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| CHD7 |
Q9P2D1
|
chromodomain helicase DNA binding protein 7
|
|
1.00 |
0.441 |
0.846 |
| RAD51 |
Q06609
|
RAD51 recombinase
|
|
2.7E-02 |
0.447 |
0.846 |
| FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
| FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
| PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
| SKI |
P12755
|
SKI proto-oncogene
|
|
1.00 |
0.503 |
0.808 |
| RREB1 |
Q92766
|
ras responsive element binding protein 1
|
|
1.00 |
0.500 |
0.808 |
| FANCC |
Q00597
|
FA complementation group C
|
|
2.8E-13 |
0.507 |
0.808 |
| JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
| FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
| GP1BB |
P13224
|
glycoprotein Ib platelet subunit beta
|
|
0.51 |
0.524 |
0.769 |
| GLA |
P06280
|
galactosidase alpha
|
|
1.00 |
0.537 |
0.769 |
| XRCC2 |
O43543
|
X-ray repair cross complementing 2
|
|
4.0E-07 |
0.512 |
0.731 |
| RAD51C |
O43502
|
RAD51 paralog C
|
|
6.2E-14 |
0.533 |
0.692 |
| MYH3 |
P11055
|
myosin heavy chain 3
|
|
6.7E-21 |
0.563 |
0.654 |
| FANCF |
Q9NPI8
|
FA complementation group F
|
|
0.46 |
0.535 |
0.731 |
| UFD1 |
Q92890
|
ubiquitin recognition factor in ER associated degradation 1
|
|
1.00 |
0.537 |
0.769 |
| FANCI |
Q9NVI1
|
FA complementation group I
|
|
8.9E-37 |
0.543 |
0.731 |
| MAD2L2 |
Q9UI95
|
mitotic arrest deficient 2 like 2
|
|
8.2E-02 |
0.547 |
0.731 |
| FANCE |
Q9HB96
|
FA complementation group E
|
|
1.5E-06 |
0.553 |
0.808 |
| UBE2T |
Q9NPD8
|
ubiquitin conjugating enzyme E2 T
|
|
1.1E-05 |
0.550 |
0.731 |
| FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
| SLX4 |
Q8IY92
|
SLX4 structure-specific endonuclease subunit
|
|
1.6E-22 |
0.565 |
0.731 |
| TMEM70 |
Q9BUB7
|
transmembrane protein 70
|
|
2.9E-02 |
0.636 |
0.654 |